Tracker target launches R&D, training division


Tracker Ventures Corp.’s amalgamation target Contakt LLC, a technology company modernizing public health and safety, has launched its research, development, training division to spearhead continued development of breakthrough public health and safety technologies by conducting university research and by seeking financing through non-dilutive grants.

The RDT division is expected to play a critical role in non-dilutive capital formation for Contakt World through recurring applications for grants bolstered by the expertise and scale of the FreeMind Group, which has successfully garnered over $1.5-billion (U.S.) in awards for its clients. FreeMind will assist Contakt World with strategy and frequent applications from agencies in the United States such as National Institutes of Health, Department of Defense, Biomedical Advanced Research Development Authority, National Science Foundation and through private foundations.

Through academic research partnerships, internal consultations, its engagement of FreeMind, and internal and external training programs, the RDT division will support Contakt World’s goal to connect health agencies with their communities. Leveraging FreeMind’s expertise, the RDT division is expected to finance commercial deployment of Contakt World solutions to underresourced local health agencies, identify gaps that exist in public health agency technologies, improve existing solutions and develop new solutions that improve public health and safety for a mid- and postpandemic world.

Key priorities for the RDT division include:

Establishing multiple academic research partnerships to create a pipeline of meaningful research to study vulnerable populations and disruptive innovation for public health. Initial research involving Contakt World commenced at the Sue and Bill Gross School of Nursing and University of California, Irvine, in 2020, recently expanding to Franciscan Missionaries of Our Lady University in Louisiana and Augusta University in Georgia;
Developing grant programs that finance Contakt World to deploy its solutions in underresourced health agencies, including but not limited to the approximately 2,000 local health agencies in the United States, which presently serve populations of less than 50,000; and
Creating internal and external training and education modules to support deployment and enhance scalability of Contakt World’s public health and safety technologies, including its contact tracing platform and community messaging solutions.
“The RDT division demonstrates Contakt World’s commitment to health equity, serving vulnerable populations and innovation in public health, which has been historically underresourced and underappreciated,” said Riaz Ferdaus, PhD, MBBS, vice-president of research, Contakt World. “We hope that our programs, which are specifically guided or driven by meaningful academic research and affiliations with leading associations like the National Association of County and City Health Officials, will improve contact tracing, trust in vaccines and health agency resources. With our recent retention of FreeMind, we hope to financially support our programs with non-dilutive capital through grants and further establish Contakt World as an industry leader in public health and safety.”